Form D · Other
Agilis Medical, Inc.
Cardiff, CA · CIK 0002162505
Offering snapshot reported Oct 28, 2026 · SEC filing
- Reported sold
- $4M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Oct 26, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 28, 2026 | Initial | $4,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-602787
Source: Form D, filed Oct 28, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Benjamin Arnold | Director, Executive |
| Brian Bowman | Executive |
| Michael Collins | Director, Executive |
| Renu Parker | Director |
Issuer details
Industry: Other (See others in industry)
Address:
230 Birmingham Drive Ste 200
Cardiff, CA, 92007
Cardiff, CA, 92007